Food ingredients to be used in food

Draft Amendment for "The Use Restrictions and Labeling Requirements of 2'-fucosyllactose Produced by Genetically Modified Escherichia coli strain BL21 (DE3) #1540 as a Food Ingredient" and "The Use Restrictions and Labeling Requirements of 2'-fucosyllactose Produced by Genetically Modified Escherichia coli strain K-12 DH1 MDO MAP1001d as a Food Ingredient". Language(s): English. Number of pages: 6

"The Use Restrictions and Labeling Requirement of 2'‑fucosyllactose Produced by Genetically Modified Escherichia coli strain BL21 (DE3) #1540 as a Food Ingredient" and "The Use Restriction and Labeling Requirement of 2'‑fucosyllactose Produced by Genetically Modified Escherichia coli strain K-12 DH1 MDO MAP1001d as a Food Ingredient" were promulgated and came into effect on 16 December 2020 and 16 June 2021, respectively. 2'-fucosyllactose referred to above regulations can be used for infant formula, follow-up infant formula and milk powder or similar products for children under seven years old.

In accordance with the provisions of subparagraph 2 of Article 3 of the Act Governing Food Safety and Sanitation and Article 2 of the Enforcement Rules of the Act Governing Food Safety and Sanitation, the term "infant and follow-up formula" prescribed in the Act shall include infant formula, follow-up infant formula and infant formula for special medical purposes. Therefore, this draft amendment specifies to extend "infant formula for special medical purposes" to the usage scope, other use restrictions and labeling requirements have not changed.